MiNK Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MiNK Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $540.00, a 91.41% decline year-over-year.
- MiNK Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $6.29K, a 71.44% decline year-over-year.
- MiNK Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $22.02K, a 7215.61% increase year-over-year.
- MiNK Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $494.00, a 229.33% increase year-over-year.
- MiNK Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $1.59K, a 963.33% increase from fiscal 2021.
- MiNK Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $150.00, a 83.33% decline from fiscal 2020.
- MiNK Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $900.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $540.00 10-Q · filed 2026-08-13 | |
| 2024-06-30 | $6.29K 10-Q · filed 2025-11-14 | |
| 2023-06-30 | $22.02K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $1.59K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $494.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $301.00 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $689.00 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $150.00 10-K · filed 2023-03-24 | |
| 2021-09-30 | $150.00 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $900.00 10-K · filed 2022-03-18 | |
| 2020-09-30 | $350.00 10-Q · filed 2021-11-29 | |
| 2020-06-30 | $150.00 10-Q · filed 2021-11-29 | |
| 2020-03-31 | $400.00 10-Q · filed 2021-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |